News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
644,396 Results
Type
Article (61251)
Company Profile (69)
Press Release (583076)
Multimedia
Podcasts (59)
Webinars (13)
Section
Business (173621)
Career Advice (2729)
Deals (32421)
Drug Delivery (97)
Drug Development (76804)
Employer Resources (150)
FDA (14927)
Job Trends (13878)
News (304727)
Policy (28923)
Tag
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (9)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (5)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (2)
2026 BioCapital Standard (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Genetown Standard (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2893)
Academic (2)
Accelerated approval (6)
Adcomms (22)
Allergies (88)
Alliances (43117)
ALS (88)
Alzheimer's disease (1322)
Antibody-drug conjugate (ADC) (109)
Approvals (14944)
Artificial intelligence (262)
Autoimmune disease (23)
Automation (15)
Bankruptcy (290)
Best Places to Work (10853)
BIOSECURE Act (16)
Biosimilars (101)
Biotechnology (51)
Bladder cancer (77)
Brain cancer (27)
Breast cancer (273)
Cancer (2175)
Cardiovascular disease (164)
Career advice (2312)
Career pathing (33)
CAR-T (153)
Cell therapy (427)
Cervical cancer (20)
Clinical research (62450)
Collaboration (784)
Compensation (321)
Complete response letters (20)
COVID-19 (2571)
CRISPR (43)
C-suite (259)
Cystic fibrosis (100)
Data (2143)
Decentralized trials (2)
Denatured (25)
Depression (42)
Diabetes (251)
Diagnostics (6151)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (39)
Drug discovery (114)
Drug pricing (97)
Drug shortages (23)
Duchenne muscular dystrophy (86)
Earnings (60054)
Editorial (38)
Employer branding (18)
Employer resources (132)
Events (94334)
Executive appointments (759)
FDA (16168)
Featured Employer (26)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (745)
Gene editing (109)
Generative AI (20)
Gene therapy (298)
GLP-1 (663)
Government (4456)
Grass and pollen (6)
Guidances (56)
Healthcare (18233)
Huntington's disease (19)
IgA nephropathy (25)
Immunology and inflammation (108)
Indications (28)
Infectious disease (2704)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (96)
Interviews (526)
IPO (14796)
IRA (38)
Job creations (3411)
Job search strategy (1941)
Kidney cancer (10)
Labor market (30)
Layoffs (501)
Leadership (22)
Legal (6431)
Liver cancer (69)
Lung cancer (304)
Lymphoma (144)
Machine learning (7)
Management (53)
Manufacturing (275)
MASH (62)
Medical device (12653)
Medtech (12658)
Mergers & acquisitions (18200)
Metabolic disorders (628)
Multiple sclerosis (77)
NASH (13)
Neurodegenerative disease (84)
Neuropsychiatric disorders (26)
Neuroscience (1838)
NextGen: Class of 2025 (6373)
Non-profit (4315)
Northern California (2397)
Now hiring (12)
Obesity (318)
Opinion (232)
Ovarian cancer (71)
Pain (90)
Pancreatic cancer (79)
Parkinson's disease (143)
Partnered (21)
Patents (234)
Patient recruitment (110)
Peanut (50)
People (59541)
Pharmaceutical (20)
Pharmacy benefit managers (15)
Phase I (19654)
Phase II (27551)
Phase III (20125)
Pipeline (1124)
Policy (124)
Postmarket research (2468)
Preclinical (8387)
Press Release (67)
Prostate cancer (107)
Psychedelics (27)
Radiopharmaceuticals (249)
Rare diseases (360)
Real estate (5985)
Recruiting (61)
Regulatory (20079)
Reports (33)
Research institute (2396)
Resumes & cover letters (405)
Rett syndrome (5)
RNA editing (3)
RSV (35)
Schizophrenia (67)
Series A (130)
Series B (86)
Service/supplier (9)
Sickle cell disease (51)
Southern California (2112)
Special edition (10)
Spinal muscular atrophy (146)
Sponsored (29)
Startups (3341)
State (1)
Stomach cancer (9)
Supply chain (54)
Tariffs (25)
The Weekly (32)
United States (21138)
Vaccines (662)
Venture capitalists (34)
Weight loss (202)
Women's health (30)
Worklife (19)
Date
Today (132)
Last 7 days (812)
Last 30 days (2465)
Last 365 days (30549)
2025 (10017)
2024 (32288)
2023 (36372)
2022 (46646)
2021 (51582)
2020 (50722)
2019 (44770)
2018 (34059)
2017 (30711)
2016 (30054)
2015 (35431)
2014 (28371)
2013 (24946)
2012 (26204)
2011 (26449)
2010 (24937)
Location
Africa (871)
Alabama (54)
Alaska (6)
Arizona (170)
Arkansas (14)
Asia (38039)
Australia (6846)
California (5526)
Canada (1841)
China (484)
Colorado (247)
Connecticut (257)
Delaware (138)
Europe (88654)
Florida (844)
Georgia (198)
Idaho (56)
Illinois (545)
India (25)
Indiana (277)
Iowa (10)
Japan (152)
Kansas (95)
Kentucky (23)
Louisiana (10)
Maine (61)
Maryland (825)
Massachusetts (4003)
Michigan (221)
Minnesota (336)
Mississippi (2)
Missouri (87)
Montana (29)
Nebraska (23)
Nevada (59)
New Hampshire (61)
New Jersey (1632)
New Mexico (29)
New York (1618)
North Carolina (952)
North Dakota (9)
Northern California (2397)
Ohio (192)
Oklahoma (15)
Oregon (36)
Pennsylvania (1229)
Puerto Rico (12)
Rhode Island (31)
South America (1176)
South Carolina (17)
South Dakota (1)
Southern California (2112)
Tennessee (95)
Texas (844)
Utah (172)
Virginia (141)
Washington D.C. (49)
Washington State (509)
West Virginia (3)
Wisconsin (58)
644,396 Results for "university of gothenburg".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
IRLAB to Present at Life Science-dagen in Gothenburg and have a Fireside Chat with ABG
IRLAB Therapeutics Gothenburg, Sweden, February 29, 2024 - IRLAB Therapeutics AB, a company discovering and developing novel treatments for Parkinson’s disease, announced that the company will present at the event Life Science-dagen in Gothenburg on March 6.
February 29, 2024
·
2 min read
Medivir to present at the Life Science Day in Gothenburg on March 6
Medivir AB, a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that the company will participate at the Life Science Day in Gothenburg on March 6, 2024.
March 4, 2024
·
1 min read
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
Drug Development
Alzheon to Present Biomarker, Brain Preservation and Clinical Effects of Oral Tablet ALZ-801 (Valiltramiprosate) at Upcoming AD/PD 2023 Conference in Gothenburg, Sweden
Alzheon, Inc. announced that it will be presenting interim findings from an ongoing Phase 2 study evaluating ALZ-801 tablet at the upcoming AD/PD 2023 Conference to be held from March 28 – April 1, 2023 in Gothenburg, Sweden.
March 22, 2023
·
9 min read
Pharm Country
Cognition Therapeutics Latest Episode of “Conversations” Podcast Features Biomarker Experts from Gothenburg University, Emory and Amsterdam UMC
Cognition Therapeutics, Inc. , (Nasdaq: CGTX), (the “Company” or “Cognition”) has released its fifth “Conversations” video podcast, a review and interactive discussion of Cognition’s CT1812 biomarker results presented at AD/PD™ 2023, the Alzheimer’s & Parkinson’s Diseases Conference.
May 23, 2023
·
6 min read
Layoffs
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
October 10, 2024
·
1 min read
·
Angela Gabriel
Press Releases
LIfT BioSciences announces partnership with University of Galway for clinical trial in Ireland
April 28, 2025
·
4 min read
Press Releases
University Hospitals Cleveland Medical Center Activates AI for Early Lung Cancer Identification
April 2, 2025
·
4 min read
IRLAB’s Pioneering Phase IIb Study with Pirepemat - React-PD - Provides New Insights in Specific Parkinson’s Patient Population and Enables a Data Driven Prediction of Study Timelines
IRLAB Therapeutics Gothenburg, Sweden, February 6, 2024 - IRLAB Therapeutics AB is a company discovering and developing novel treatments for Parkinson’s disease.
February 6, 2024
·
7 min read
Press Releases
Breakthrough T1D Awards $2.8 Million in Funding to Expand Center of Excellence at University of Michigan and Oregon Health & Science University to Accelerate Type 1 Diabetes Research
April 24, 2025
·
5 min read
1 of 64,440
Next
